AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 145 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,416,790 | +751205.6% | 377,400 | +66.5% | 0.03% | +766.7% |
| Q4 2023 | $2,052 | +190.2% | 226,700 | +104.6% | 0.00% | +200.0% |
| Q3 2023 | $707 | -3.3% | 110,800 | +68.1% | 0.00% | 0.0% |
| Q2 2023 | $731 | -87.3% | 65,900 | -82.4% | 0.00% | -87.5% |
| Q1 2023 | $5,758 | +55.7% | 375,100 | +125.2% | 0.01% | +60.0% |
| Q4 2022 | $3,697 | -99.8% | 166,600 | +34.4% | 0.01% | +66.7% |
| Q3 2022 | $2,025,000 | +28.7% | 124,000 | +14.5% | 0.00% | +50.0% |
| Q2 2022 | $1,574,000 | +122.0% | 108,300 | +182.0% | 0.00% | +100.0% |
| Q1 2022 | $709,000 | +156.9% | 38,400 | +231.0% | 0.00% | – |
| Q4 2021 | $276,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |